Subcutaneous immunization with heat shock protein-65 reduces atherosclerosis in Apoe -/- mice

Roland Klingenberg, Daniel F J Ketelhuth, Daniela Strodthoff, Silvia Gregori, Göran K. Hansson

Research output: Contribution to journalArticle

Abstract

Objective: To modulate atherosclerosis by combining subcutaneous immunization with heat shock protein 65 (hsp65) in alum adjuvant and anti-CD45RB monoclonal antibodies (mAb). Methods: 8 week old Apoe -/- mice on normal chow were treated for 12 weeks: group A received hsp65-alum immunization combined with anti-CD45RB mAb, group B hsp65-alum immunization combined with isotype control antibody, and group C mock vaccine combined with isotype control antibody. Results: Unexpectedly, atherosclerotic lesions in the aortic root were significantly reduced in both hsp65-alum immunization groups (A and B) compared with the control group (C). Significantly elevated antibody titers against hsp65 were detected in both groups along with a significant increase in MHC class II expression on B cells. Body weight, total cholesterol and triglyceride levels were not different between groups. Treatment with anti-CD45RB antibody mediated a shift on CD4 + T cells from the CD45RB high to CD45RB low isoform with a relative increase in CD4 +Foxp3 + regulatory T cells (Treg) in an overall reduced T cell pool. Furthermore, anti-CD45RB treatment mediated a transient reduction of peripheral leukocytes and increased IFN-γ and IL-17A plasma levels. Conclusions: Subcutaneous immunization with hsp65-alum protects Apoe -/- mice against progression of early atherosclerosis. Administration of anti-CD45RB antibody provided no incremental benefit to the athero-protective effects of hsp65-alum treatment alone.

Original languageEnglish
Pages (from-to)540-547
Number of pages8
JournalImmunobiology
Volume217
Issue number5
DOIs
Publication statusPublished - May 2012

Fingerprint

Apolipoproteins E
Heat-Shock Proteins
Immunization
Atherosclerosis
Antibodies
Anti-Idiotypic Antibodies
Monoclonal Antibodies
Combined Vaccines
T-Lymphocytes
Control Groups
Interleukin-17
Regulatory T-Lymphocytes
aluminum sulfate
Protein Isoforms
Triglycerides
Leukocytes
B-Lymphocytes
Therapeutics
Cholesterol
Body Weight

Keywords

  • Atherosclerosis
  • Immune system
  • Immunomodulation
  • Leukocytes
  • Vascular biology

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Hematology

Cite this

Subcutaneous immunization with heat shock protein-65 reduces atherosclerosis in Apoe -/- mice. / Klingenberg, Roland; Ketelhuth, Daniel F J; Strodthoff, Daniela; Gregori, Silvia; Hansson, Göran K.

In: Immunobiology, Vol. 217, No. 5, 05.2012, p. 540-547.

Research output: Contribution to journalArticle

Klingenberg, Roland ; Ketelhuth, Daniel F J ; Strodthoff, Daniela ; Gregori, Silvia ; Hansson, Göran K. / Subcutaneous immunization with heat shock protein-65 reduces atherosclerosis in Apoe -/- mice. In: Immunobiology. 2012 ; Vol. 217, No. 5. pp. 540-547.
@article{26576c570c76468a8a6c018d7e7aebbe,
title = "Subcutaneous immunization with heat shock protein-65 reduces atherosclerosis in Apoe -/- mice",
abstract = "Objective: To modulate atherosclerosis by combining subcutaneous immunization with heat shock protein 65 (hsp65) in alum adjuvant and anti-CD45RB monoclonal antibodies (mAb). Methods: 8 week old Apoe -/- mice on normal chow were treated for 12 weeks: group A received hsp65-alum immunization combined with anti-CD45RB mAb, group B hsp65-alum immunization combined with isotype control antibody, and group C mock vaccine combined with isotype control antibody. Results: Unexpectedly, atherosclerotic lesions in the aortic root were significantly reduced in both hsp65-alum immunization groups (A and B) compared with the control group (C). Significantly elevated antibody titers against hsp65 were detected in both groups along with a significant increase in MHC class II expression on B cells. Body weight, total cholesterol and triglyceride levels were not different between groups. Treatment with anti-CD45RB antibody mediated a shift on CD4 + T cells from the CD45RB high to CD45RB low isoform with a relative increase in CD4 +Foxp3 + regulatory T cells (Treg) in an overall reduced T cell pool. Furthermore, anti-CD45RB treatment mediated a transient reduction of peripheral leukocytes and increased IFN-γ and IL-17A plasma levels. Conclusions: Subcutaneous immunization with hsp65-alum protects Apoe -/- mice against progression of early atherosclerosis. Administration of anti-CD45RB antibody provided no incremental benefit to the athero-protective effects of hsp65-alum treatment alone.",
keywords = "Atherosclerosis, Immune system, Immunomodulation, Leukocytes, Vascular biology",
author = "Roland Klingenberg and Ketelhuth, {Daniel F J} and Daniela Strodthoff and Silvia Gregori and Hansson, {G{\"o}ran K.}",
year = "2012",
month = "5",
doi = "10.1016/j.imbio.2011.06.006",
language = "English",
volume = "217",
pages = "540--547",
journal = "Immunobiology",
issn = "0171-2985",
publisher = "Urban und Fischer Verlag GmbH und Co. KG",
number = "5",

}

TY - JOUR

T1 - Subcutaneous immunization with heat shock protein-65 reduces atherosclerosis in Apoe -/- mice

AU - Klingenberg, Roland

AU - Ketelhuth, Daniel F J

AU - Strodthoff, Daniela

AU - Gregori, Silvia

AU - Hansson, Göran K.

PY - 2012/5

Y1 - 2012/5

N2 - Objective: To modulate atherosclerosis by combining subcutaneous immunization with heat shock protein 65 (hsp65) in alum adjuvant and anti-CD45RB monoclonal antibodies (mAb). Methods: 8 week old Apoe -/- mice on normal chow were treated for 12 weeks: group A received hsp65-alum immunization combined with anti-CD45RB mAb, group B hsp65-alum immunization combined with isotype control antibody, and group C mock vaccine combined with isotype control antibody. Results: Unexpectedly, atherosclerotic lesions in the aortic root were significantly reduced in both hsp65-alum immunization groups (A and B) compared with the control group (C). Significantly elevated antibody titers against hsp65 were detected in both groups along with a significant increase in MHC class II expression on B cells. Body weight, total cholesterol and triglyceride levels were not different between groups. Treatment with anti-CD45RB antibody mediated a shift on CD4 + T cells from the CD45RB high to CD45RB low isoform with a relative increase in CD4 +Foxp3 + regulatory T cells (Treg) in an overall reduced T cell pool. Furthermore, anti-CD45RB treatment mediated a transient reduction of peripheral leukocytes and increased IFN-γ and IL-17A plasma levels. Conclusions: Subcutaneous immunization with hsp65-alum protects Apoe -/- mice against progression of early atherosclerosis. Administration of anti-CD45RB antibody provided no incremental benefit to the athero-protective effects of hsp65-alum treatment alone.

AB - Objective: To modulate atherosclerosis by combining subcutaneous immunization with heat shock protein 65 (hsp65) in alum adjuvant and anti-CD45RB monoclonal antibodies (mAb). Methods: 8 week old Apoe -/- mice on normal chow were treated for 12 weeks: group A received hsp65-alum immunization combined with anti-CD45RB mAb, group B hsp65-alum immunization combined with isotype control antibody, and group C mock vaccine combined with isotype control antibody. Results: Unexpectedly, atherosclerotic lesions in the aortic root were significantly reduced in both hsp65-alum immunization groups (A and B) compared with the control group (C). Significantly elevated antibody titers against hsp65 were detected in both groups along with a significant increase in MHC class II expression on B cells. Body weight, total cholesterol and triglyceride levels were not different between groups. Treatment with anti-CD45RB antibody mediated a shift on CD4 + T cells from the CD45RB high to CD45RB low isoform with a relative increase in CD4 +Foxp3 + regulatory T cells (Treg) in an overall reduced T cell pool. Furthermore, anti-CD45RB treatment mediated a transient reduction of peripheral leukocytes and increased IFN-γ and IL-17A plasma levels. Conclusions: Subcutaneous immunization with hsp65-alum protects Apoe -/- mice against progression of early atherosclerosis. Administration of anti-CD45RB antibody provided no incremental benefit to the athero-protective effects of hsp65-alum treatment alone.

KW - Atherosclerosis

KW - Immune system

KW - Immunomodulation

KW - Leukocytes

KW - Vascular biology

UR - http://www.scopus.com/inward/record.url?scp=84858797859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858797859&partnerID=8YFLogxK

U2 - 10.1016/j.imbio.2011.06.006

DO - 10.1016/j.imbio.2011.06.006

M3 - Article

C2 - 21798617

AN - SCOPUS:84858797859

VL - 217

SP - 540

EP - 547

JO - Immunobiology

JF - Immunobiology

SN - 0171-2985

IS - 5

ER -